Latest filing published 16 May 2022 for Akebia Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Violetta Cotreau: trading record in brief
This profile gathers the share dealings of Violetta Cotreau in Akebia Therapeutics, Inc., where the filings describe the role as senior executive. Between 26 February 2021 and 12 May 2022, the trades on record add up to 5 filings.
On the market, this insider has only sold: 2 sales, €19k in total. Besides market trades, the filings include 3 share grants. In 2022 alone, the filings show no purchases and 2 sales.
Most recently, on 16 May 2022, the filings show a share grant in Akebia Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Violetta Cotreau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares0Common StockSEC:0001562180-22-004030:0
- 3,946 shares@ US$2.154839.3% of flowCommon StockSEC:0001562180-22-002164:0
- 5,833 shares@ US$2.286260.7% of flowCommon StockSEC:0001562180-22-000236:0
3 of 3 declarations
